Create a narrative

BioArctic Community

OM:BIOA B Community

1 Narratives written by author
0 Comments on narratives written by author
33 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

Regulatory Approvals And Pipeline Progress Will Redefine Neurodegeneration Care

Key Takeaways Regulatory approvals and upcoming diagnostics are set to accelerate Leqembi adoption, expanding access and recurring royalty revenues from an underserved and growing patient base. Diversified pipeline and technology partnerships position BioArctic for long-term growth beyond current products, adding high-margin revenue streams and multi-indication opportunities.

SEK 288.40

FV

19.0% undervalued

12.82%

Revenue growth p.a.

0

0

17

6 days ago